SENSITIVE DETECTION OF SARS-COV-2 USING AN ENZYME-LINKED OLIGONUCLEOTIDE ASSAY

Simple item page
dc.contributor.authorShola David, Michael
dc.date.accessioned2022-08-11T06:05:42Z
dc.date.available2022-08-11T06:05:42Z
dc.date.issued2022-06
dc.description.abstractThe rapid spread of COVID’19 has necessitated the need for the development of rapid diagnostic techniques as a strategy to contain further transmission of the virus. Aptamer-based detection assay like enzyme-linked oligonucleotide assay (ELONA) is promising as it is cheaper to run with high sensitivity and specificity. Aptamers offer a potential advantage over antibodies in the characteristics of broad modification, small size, in vitro selection, and stability under stringent conditions, which assist the creation of scalable and reliable detection. In this study, we sought to develop a simple and sensitive ELONA detection tool for SARS-CoV-2 using specific aptamers against SARS-CoV-2 RBD S protein. Screening of CoV2-RBD-1C and CoV2-RBD-4C aptamers and optimization of the assay conditions led to the development of a direct ELONA able to detect SARS-CoV-2 RBD S protein in buffer solution and spiked in 0.1% human nasal fluid with a detection limit of 2.16 ng/mL and 1.02 ng/mL, respectively. To further test the practicality of the developed assay, we successfully detected inactivated Alpha, Wuhan, and Delta variants of SARS CoV-2 with a detection limit of 3.73, 5.72, and 6.02 TCID50/mL respectively. Furthermore, we applied the two aptamers as capture and reporter elements to develop a more sensitive sandwich assay to detect the three variants of SARS-CoV-2 used in this study, and as expected a lower detection limit was obtained as follows: 2.31 TCID50/mL for Alpha variant, 1.15 TCID50/mL for Wuhan variant, and 2.96 TCID50/mL for Delta variant, which validated the high sensitivity of the sandwich assay. The sandwich ELONA was also capable of detecting both Alpha as well as Wuhan variants spiked in 0.1% human nasal fluid in a viral titer of 104 TCID50/mL. Finally, an SEM study was conducted to visualize the presence of viral particles in the Delta variant sample obtained. The results of this study have demonstrated the possibility and usefulness of our aptamer-based assay for the clinical diagnosis of SARS-COV-2en_US
dc.identifier.citationMichael Shola David. 2022. Sensitive detection of SARS-COV-2 using an enzyme-linked oligonucleotide assay. School of Sciences and Humanitiesen_US
dc.identifier.urihttp://nur.nu.edu.kz/handle/123456789/6571
dc.language.isoenen_US
dc.publisherNazarbayev University School of Sciences and Humanitiesen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.subjectType of access: Embargoen_US
dc.subjectSARS-CoV-2en_US
dc.subjectRBDen_US
dc.subjectspike proteinen_US
dc.subjectaptamersen_US
dc.subjectELONAen_US
dc.subjectdetectionen_US
dc.titleSENSITIVE DETECTION OF SARS-COV-2 USING AN ENZYME-LINKED OLIGONUCLEOTIDE ASSAYen_US
dc.typeMaster's thesisen_US
workflow.import.sourcescience

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Msc thesis Michael Shola David.pdf
Size:
2.09 MB
Format:
Adobe Portable Document Format
Description:
thesis
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
6.28 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

02. Master's Thesis